Azra AI's artificial intelligence (AI) software, which identifies incidental lung nodules in medical reports, is expanding to detect other types of cancers.
The company has expanded the clinical applications for the software to identify aneurysms and liver, kidney, adrenal, pancreatic, and ovarian cancers. The technology aims to detect cancers before patients have symptoms.
